Reduction of anthracycline-induced cardiotoxicity

Details Reduction of anthracycline-induced cardiotoxicity Reduction of anthracycline-induced cardiotoxicity

A - Human Necessities

61

K

167/184, 167/223

A61K 31/495 (2006.01) A61K 33/24 (2006.01) A61K 31/71 (1995.01)

Patent

CA 1337590

Disclosed is a method for preventing cardiotoxicity in a human in need of such preventive treatment, the method including administering an effective amount of a bisdioxopiperazine. Also disclosed is a method for preventing cardiotoxicity induced by the administration of an anthracycline. Further, a tumoricidal, cardioprotective combination of agents is disclosed.

579685

Affiliated with

Also associated with

Rating

Reduction of anthracycline-induced cardiotoxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduction of anthracycline-induced cardiotoxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of anthracycline-induced cardiotoxicity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1300693